J06A Immune sera

J06AA Immune sera

:J06AA01

Diphtheria antitoxin Diphtheria antitoxin (DAT) is a medication made up of antibodies used in the treatment of diphtheria. It is no longer recommended for prevention of diphtheria. It is administered through injection into a vein or muscle. Side effects are com ...

:J06AA02 Tetanus antitoxin :J06AA03

Snake venom antiserum Snakes are elongated limbless reptiles of the suborder Serpentes (). Cladistically squamates, snakes are ectothermic, amniote vertebrates covered in overlapping scales much like other members of the group. Many species of snakes have skulls ...

:J06AA04 Botulinum antitoxin :J06AA05 Gas-gangrene sera :J06AA06 Rabies serum

J06B Immunoglobulins

J06BA Immunoglobulins, normal human

:J06BA01 Immunoglobulins, normal human, for extravascular administration :J06BA02 Immunoglobulins, normal human, for intravascular administration

J06BB Specific
immunoglobulins An antibody (Ab) or immunoglobulin (Ig) is a large, Y-shaped protein belonging to the immunoglobulin superfamily which is used by the immune system to identify and neutralize antigens such as bacteria and viruses, including those that cause di ...

:J06BB01 Anti-D (rh) immunoglobulin :J06BB02

Tetanus immunoglobulin Anti-tetanus immunoglobulin, also known as tetanus immune globulin (TIG) and tetanus antitoxin, is a medication made up of antibodies against the tetanus toxin. It is used to prevent tetanus in those who have a wound that is at high risk, hav ...

:J06BB03 Varicella/zoster immunoglobulin :J06BB04

Hepatitis B immunoglobulin Hepatitis B immunoglobulin (HBIG) is a human immunoglobulin that is used to prevent the development of hepatitis B and is used for the treatment of acute exposure to HBsAg. Medical uses HBIG is indicated as a postexposure prophylaxis for people ...

:J06BB05

Rabies immunoglobulin Rabies, a viral zoonotic neglected tropical disease, poses a severe public health threat in over 150 countries and territories, primarily in Asia and Africa. Each year, this disease results in tens of thousands of fatalities, with children unde ...

:J06BB06

Rubella Rubella, also known as German measles or three-day measles, is an infection caused by the rubella virus. This disease is often mild, with half of people not realizing that they are infected. A rash may start around two weeks after exposure and ...

immunoglobulin :J06BB07 Vaccinia immunoglobulin :J06BB08

Staphylococcus ''Staphylococcus'', from Ancient Greek σταφυλή (''staphulḗ''), meaning "bunch of grapes", and (''kókkos''), meaning "kernel" or " Kermes", is a genus of Gram-positive bacteria in the family Staphylococcaceae from the order Bacillale ...

immunoglobulin :J06BB09

Cytomegalovirus ''Cytomegalovirus'' (CMV) (from ''cyto-'' 'cell' via Greek - 'container' + 'big, megalo-' + -''virus'' via Latin 'poison') is a genus of viruses in the order '' Herpesvirales'', in the family '' Herpesviridae'', in the subfamily '' Betaherp ...

immunoglobulin :J06BB10

Diphtheria Diphtheria is an infection caused by the bacteria, bacterium ''Corynebacterium diphtheriae''. Most infections are asymptomatic or have a mild Course (medicine), clinical course, but in some outbreaks, the mortality rate approaches 10%. Signs a ...

immunoglobulin :J06BB11

Hepatitis A Hepatitis A is an infectious liver disease caused by Hepatitis A virus (HAV); it is a type of viral hepatitis. Many cases have few or no symptoms, especially in the young. The time between infection and symptoms, in those who develop them, is ...

immunoglobulin :J06BB12 Encephalitis, tick-borne immunoglobulin :J06BB13

Pertussis Whooping cough ( or ), also known as pertussis or the 100-day cough, is a highly contagious, vaccine-preventable bacterial disease. Initial symptoms are usually similar to those of the common cold with a runny nose, fever, and mild cough, bu ...

immunoglobulin :J06BB14 Morbilli immunoglobulin :J06BB15

Parotitis Parotitis is an inflammation of one or both parotid glands, the major salivary glands located on either side of the face, in humans. The parotid gland is the salivary gland most commonly affected by inflammation. Etymology From Greek παρωτῖ ...

immunoglobulin :J06BB19 Anthrax immunoglobulin :J06BB30 Combinations

J06BC Antibacterial monoclonal antibodies

:J06BC01

Nebacumab Nebacumab is a human monoclonal antibody developed for the treatment of sepsis. It has been withdrawn in 1993 because it failed to reduce mortality in clinical trial Clinical trials are prospective biomedical or behavioral research studies on ...

:J06BC02 Raxibacumab :J06BC03

Bezlotoxumab Bezlotoxumab, sold under the brand name Zinplava, is a human monoclonal antibody designed for the prevention of recurrence of Clostridioides difficile infection, ''Clostridioides difficile'' infections. Bezlotoxumab binds to ''Clostridioides di ...

:J06BC04 Obiltoxaximab

J06BD Antiviral monoclonal antibodies

:J06BD01

Palivizumab Palivizumab, sold under the brand name Synagis, is a monoclonal antibody produced by recombinant DNA technology used to prevent severe disease caused by respiratory syncytial virus (RSV) infections. It is recommended for infants at high-risk for ...

:J06BD02 Motavizumab :J06BD03 Tixagevimab and cilgavimab :J06BD04 Ansuvimab :J06BD05

Sotrovimab Sotrovimab, sold under the brand name Xevudy, is a human neutralizing monoclonal antibody with activity against severe acute respiratory syndrome coronavirus 2, known as Severe acute respiratory syndrome coronavirus 2, SARS-CoV-2. Text was co ...

:J06BD06 Regdanvimab :J06BD07 Casirivimab and imdevimab :J06BD08

Nirsevimab Nirsevimab, sold under the brand name Beyfortus, is a human recombinant monoclonal antibody with activity against respiratory syncytial virus (RSV). It is a respiratory syncytial virus (RSV) F protein‑directed fusion inhibitor that is designed ...

:J06BD09 Sipavibart

References

{{Immune sera and immunoglobulins J06